Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
Saved in:
| Title: | Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice. |
|---|---|
| Authors: | Gantner, Pierre1 pierre.gantner@chru-strasbourg.fr, Bani-Sadr, Firouze2, Garraffo, Rodolphe3, Roger, Pierre-Marie4, Treger, Michèle5, Jovelin, Thomas6, Pugliese, Pascal4, Rey, David1 |
| Source: | PLoS ONE. 10/31/2016, Vol. 11 Issue 10, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0164240 |
